Understand the source comparison
Quickcomparison
Dose Range Degarelix 80 mg–240 mg mg Abarelix 100 mg–500 mg mg Frequency Once daily Administration As directed by healthcare provider Intramuscular injection (depot formulation) Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level St
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dose Range
- Degarelix
- 80 mg–240 mg mg
- Abarelix
- 100 mg–500 mg mg
- Frequency
- Once daily
- Administration
- As directed by healthcare provider
- Intramuscular injection (depot formulation)
- Cycle Length
- Ongoing/indefinite
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Strong human trials (Phase 3 or FDA approved)
- Efficacy